Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Nick Edwards, PhD, CEO of Potato, has a “burning desire” to speed up scientific discovery. In an interview with GEN, he explained how Potato’s AI “scientist,” named Tater, recently replicated a main ...

AI startup Trillion Labs has decided to apply for the government’s additional recruitment for the **homegrown AI foundation ...

Lukson's Mixed Metal Men's Collection redefines modern masculinity by blending 18KT gold vermeil and sterling silver with lab ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Stone walls that once bore witness to cannons and watchful silence now speak in ink, colour, and form. At Al Mirani and ...

The appointment of Yao Shunyu is a statement that the next phase of AI competition will be on systems—agents that are ...

Sapio ELaiN applies the same security, auditability and data governance controls that underpin Sapio’s validated LIMS and lab informatics platform. All interactions with partner scientific ...

When Rob Levin started the hike toward Kilimanjaro, it looked daunting. He conquered the climb by relying on a micro-habit he ...

Following the success of last year’s Ithra Cultural Days Japan edition, which welcomed more than 200,000 visitors in only two ...

Researchers create Disobind, an AI tool predicting protein interactions, advancing disease biology and drug design applications.